Ress Life Investments A/S
Ress Life Investments A/S
Holbergsgade 14, 2 tv
DK-1057 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 6 January 2021
Corporate Announcement 01/2021
Ress Life Investments A/S announces the events of the annual general meeting
held on 6 January 2021.
At the annual general meeting of Ress Life Investments A/S held on Wednesday 6 January 2021, the following decisions were taken:
• The 2019/2020 Annual Report was approved – cf item 1 of the agenda.
• Appropriation of the year's result was approved - cf item 2 of the agenda.
• Søren Andersen, Jeppe Buskov, Ketil Petersen and Anne Buchardt were re-elected to the Board of Directors - cf item 3 of the agenda.
• The Remuneration Policy and the Remuneration Report was approved - cf item 4 of the agenda.
• The remuneration of the Board of Directors for the financial year 2020/2021 was
approved – cf item 5 of the agenda.
• Deloitte Statsautoriseret Revisionspartnerselskab was re-elected as auditor – cf
item 6 of the agenda.
Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@resscapital.com
Tel +46 7 366 072 42
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SkiStar AB13.12.2025 16:00:00 CET | Press release
Bulletin from Annual General Meeting of SkiStar AB
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
